Dr Edmund Chiong

Dr Edmund Chiong graduated with the degrees of Bachelor of Medicine and Surgery from the National University of Singapore in 1995. He obtained 2 postgraduate qualifications (Fellow of the Royal College of Surgeons of Edinburgh and the Fellow of the Royal College of Surgeons In Ireland) in 2000. Upon completion of his urology specialist training in 2005, he was inducted as a Fellow of the Academy of Medicine, Singapore. Dr Chiong subsequently completed a 2-year fellowship program in Urologic Oncology at the University of Texas MD Anderson Cancer Center in Houston, Texas, USA. He is also certified by the Society of Urologic Oncology, USA. Dr Chiong’s subspecialty interests include managing and performing surgery for prostate cancers, bladder cancers, kidney cancers, testes cancers, penile cancers, and performing DaVinci robotic surgery. He started the Prostate Cancer Cryotherapy service in NUH in 2011. Dr Chiong also manages general urologic diseases and is a kidney transplant surgeon with the Ministry of Health’s renal transplantation team. Apart from clinical practice, Dr Chiong is also actively involved in both clinical and laboratory research. His research interests include investigating immunotherapy, gene therapy and targeted therapy for bladder cancer and new diagnostic modalities for urologic malignancies. He is an investigator in several grant-funded, clinical and basic science research projects. Dr Chiong has won a number of academic awards, authored or co-authored a number of papers in peer-reviewed journals, and has presented more than 60 abstracts at regional or international scientific meetings. He is also a reviewer for several international peer-reviewed journals. Dr Chiong is currently an Executive Committee member and a life member of the Singapore Urological Association. He is also a member of the American Urological Association and the American Society of Clinical Oncology.

Education and Fellowships

MBBS (Singapore), FRCSEd, FRCSI, FAMS (Urology)

Specialty Interests

• Urologic oncology
• Robotic surgery
• Cryotherapy for prostate cancers
• General Urology

Awards and Honours

• NUH Young Doctor Merit Award at the 7th NUS–NUH Annual Scientific Meeting 2003
• Best Poster Award at the National Healthcare Group Annual Scientific Congress 2004
• Best Clinical Podium Award & Best Basic Science Award at the Urofair (Singapore Urological Association Annual Scientific Meeting) 2005
• NHG Doctor Award at the Combined Scientific Meeting (Singapore) 2005
• Best NHG Oral Presentation Award at the Combined Scientific Meeting (Singapore) 2005
• Best Clinical Podium Award at the Urofair (Singapore Urological Association Annual Scientific Meeting) 2006
• Best Oral Presentation Award at Pitch for Funds, NLAM (NUS), 2006
• Exxon Mobil Research Fellowship For Clinicians Award 2007
• Health Manpower Development Plan (HMDP) Award 2007-2008, awarded by the Ministry of Health, Singapore
• Medical Research Fellowship award 2008-2009, awarded by the National Medical Research Council, Singapore
• ASCO Cancer Foundation Merit Award at the ASCO 2009 Genitourinary Cancers Symposium (USA)
• Young Investigator Merit Award & Best Poster Award at the National Healthcare Group 8th Annual Scientific Congress 2009
• Best Poster Award at the European Association of Urology Congress 2010 (Spain)
• Best Poster Award at the 10th Asian Congress of Urology of the Urological Association of Asia 2010 (Taiwan)

Selected Recent Publications

1. Effects of mTOR Inhibitor Everolimus (RAD001) on Bladder Cancer Cells. Chiong E, Lee I, Dadbin A, Sabichi AL, Harris L, Urbauer D, McConkey D, Dickstein RJ, Cheng T, Grossman HB. Clin Cancer Res. 2011 Mar 17 [Epub ahead of print].
2. NRAMP1 and hGPX1 Gene Polymorphism and Response to Bacillus Calmette-Guérin Therapy for Bladder Cancer. Chiong E, Kesavan A, Mahendran R, Chan YH, Sng JH, Lim YK, Kamaraj R, Tan TM, Esuvaranathan K. Eur Urol. 2011;59(3):430-7.
3. New Therapies for Non-muscle-invasive Bladder Cancer. Chiong E, Esuvaranathan K. World J Urol. 2010; 28(1):71-8.
4. The use of short tandem repeat profiling to characterize human bladder cancer cell lines. Chiong E, Dadbin A, Harris LD, Sabichi AL, Grossman HB. J Urol. 2009; 181(6):2737-48.
5. Role of cytoreductive nephrectomy in renal cell carcinoma. Chiong E, Wood CG, Margulis V. Future Oncol. 2009 Aug;5(6):859-69.
6. Predictive Value Of p53 And pRb Expression in Superficial Bladder Cancer Patients Treated with BCG And Interferon Alpha. Esuvaranathan K, Chiong E, Thamboo TP, Chan YH, Kamaraj R, Mahendran R, Teh M. Cancer 2007; 109(6):1097-1105.